Literature DB >> 29998978

The histopathology of bone marrow failure in children.

Hideto Iwafuchi.   

Abstract

Bone marrow failure (BMF) is a rare but life-threatening disorder that usually manifests as (pan)cytopenia. BMF can be caused by a variety of diseases, but inherited BMF (IBMF) syndromes are a clinically important cause, especially in children. IBMF syndromes are a heterogeneous group of genetic disorders characterized by BMF, physical abnormalities, and predisposition to malignancy. An accurate diagnosis is critical, as disease-specific management, surveillance, and genetic counselling are required for each patient. The major differential diagnoses of IBMF syndromes are acquired aplastic anemia (AA) and refractory cytopenia of childhood (RCC). These diseases have overlapping features, such as BM hypocellularity and/or dysplastic changes, which make the differential diagnosis challenging. RCC has been defined as a histomorphologically distinct entity. Therefore, understanding the BM histopathology of these diseases is essential for the differential diagnosis. However, the BM histopathological features have not been characterized in detail, as descriptions of BM histopathology are very limited due to the rarity of the diseases. This review provides a detailed description of the BM histopathology in cases of RCC, AA, and the four most common IBMF syndromes: Fanconi anemia (FA), dysketatosis congenita (DC), Diamond-Blackfan anemia (DBA), and Shwachman-Diamond syndrome (SDS). An overview, including the clinical features and diagnosis, is also provided.

Entities:  

Keywords:  aplastic anemia; bone marrow failure syndromes; children; histopathology; refractory cytopenia of childhood

Mesh:

Year:  2018        PMID: 29998978      PMCID: PMC6413145          DOI: 10.3960/jslrt.18018

Source DB:  PubMed          Journal:  J Clin Exp Hematop        ISSN: 1346-4280


  5 in total

1.  Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study.

Authors:  Kasiani C Myers; Elissa Furutani; Edie Weller; Bradford Siegele; Ashley Galvin; Valerie Arsenault; Blanche P Alter; Farid Boulad; Carlos Bueso-Ramos; Lauri Burroughs; Paul Castillo; James Connelly; Stella M Davies; Courtney D DiNardo; Iftikhar Hanif; Richard H Ho; Nicole Karras; Michelle Manalang; Lisa J McReynolds; Taizo A Nakano; Grzegorz Nalepa; Maxim Norkin; Matthew J Oberley; Etan Orgel; Yves D Pastore; Joseph Rosenthal; Kelly Walkovich; Jordan Larson; Maggie Malsch; M Tarek Elghetany; Mark D Fleming; Akiko Shimamura
Journal:  Lancet Haematol       Date:  2019-12-23       Impact factor: 18.959

2.  Influence of Mixed Chimerism on Outcome in Children With Anaemia After Haematopoietic Stem Cell Transplantation.

Authors:  Monika Lejman; Joanna Zawitkowska; Agnieszka Zaucha-Prażmo; Magdalena Cienkusz; Aleksandra Mroczkowska; Jerzy Kowalczyk; Katarzyna Drabko
Journal:  In Vivo       Date:  2019 Nov-Dec       Impact factor: 2.155

3.  Cyclosporine Monotherapy in Pediatric Patients With Non-severe Aplastic Anemia: A Retrospective Analysis.

Authors:  Hongmin Li; Lingling Fu; Bixi Yang; Hui Chen; Jie Ma; Runhui Wu
Journal:  Front Med (Lausanne)       Date:  2022-03-07

4.  SOCS1 Haploinsufficiency Presenting as Severe Enthesitis, Bone Marrow Hypocellularity, and Refractory Thrombocytopenia in a Pediatric Patient with Subsequent Response to JAK Inhibition.

Authors:  Thomas F Michniacki; Kelly Walkovich; Lauren DeMeyer; Nadine Saad; Mark Hannibal; Matthew L Basiaga; Kelly K Horst; Smriti Mohan; Liang Chen; Kailey Brodeur; Yan Du; David Frame; Sandra Ngo; Jillian Simoneau; Noah Brown; Pui Y Lee
Journal:  J Clin Immunol       Date:  2022-08-17       Impact factor: 8.542

Review 5.  Aplastic Anemia as a Roadmap for Bone Marrow Failure: An Overview and a Clinical Workflow.

Authors:  Antonio G Solimando; Carmen Palumbo; Mary Victoria Pragnell; Max Bittrich; Antonella Argentiero; Markus Krebs
Journal:  Int J Mol Sci       Date:  2022-10-04       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.